adenosine has been researched along with Scleroderma, Diffuse in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arnett, FC; Broen, J; Coenen, M; Gourh, P; Martin, J; Mayes, M; Radstake, TR; Rueda, B | 1 |
| SEVIN, W; TRINCZEK, H | 1 |
2 other study(ies) available for adenosine and Scleroderma, Diffuse
| Article | Year |
|---|---|
The FAS -670A>G polymorphism influences susceptibility to systemic sclerosis phenotypes.
Topics: Adenosine; fas Receptor; Female; Genetic Predisposition to Disease; Genotype; Guanosine; Humans; Male; Middle Aged; Phenotype; Polymorphism, Single Nucleotide; Promoter Regions, Genetic; Scleroderma, Diffuse; Scleroderma, Limited | 2009 |
[Contribution to the treatment of ulcus cruris and of progressive scleroderma with adenosine-5-monophosphoric acid (AMP)].
Topics: Adenine Nucleotides; Adenosine; Adenosine Monophosphate; Humans; Scleroderma, Diffuse; Scleroderma, Localized; Scleroderma, Systemic; Varicose Ulcer | 1959 |